These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 27103116)

  • 1. Soluble CD14 in cerebrospinal fluid is associated with markers of inflammation and axonal damage in untreated HIV-infected patients: a retrospective cross-sectional study.
    Jespersen S; Pedersen KK; Anesten B; Zetterberg H; Fuchs D; Gisslén M; Hagberg L; Trøseid M; Nielsen SD
    BMC Infect Dis; 2016 Apr; 16():176. PubMed ID: 27103116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Markers of microbial translocation predict hypertension in HIV-infected individuals.
    Manner IW; Baekken M; Kvale D; Oektedalen O; Pedersen M; Nielsen SD; Nowak P; Os I; Trøseid M
    HIV Med; 2013 Jul; 14(6):354-61. PubMed ID: 23332095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central and peripheral markers of neurodegeneration and monocyte activation in HIV-associated neurocognitive disorders.
    McGuire JL; Gill AJ; Douglas SD; Kolson DL;
    J Neurovirol; 2015 Aug; 21(4):439-48. PubMed ID: 25776526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid levels of glial marker YKL-40 strongly associated with axonal injury in HIV infection.
    Hermansson L; Yilmaz A; Axelsson M; Blennow K; Fuchs D; Hagberg L; Lycke J; Zetterberg H; Gisslén M
    J Neuroinflammation; 2019 Jan; 16(1):16. PubMed ID: 30678707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid extracellular vesicles and neurofilament light protein as biomarkers of central nervous system injury in HIV-infected patients on antiretroviral therapy.
    Guha D; Mukerji SS; Chettimada S; Misra V; Lorenz DR; Morgello S; Gabuzda D
    AIDS; 2019 Mar; 33(4):615-625. PubMed ID: 30557159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study.
    Gisslén M; Price RW; Andreasson U; Norgren N; Nilsson S; Hagberg L; Fuchs D; Spudich S; Blennow K; Zetterberg H
    EBioMedicine; 2016 Jan; 3():135-140. PubMed ID: 26870824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-free mitochondrial DNA in CSF is associated with early viral rebound, inflammation, and severity of neurocognitive deficits in HIV infection.
    Pérez-Santiago J; Schrier RD; de Oliveira MF; Gianella S; Var SR; Day TR; Ramirez-Gaona M; Suben JD; Murrell B; Massanella M; Cherner M; Smith DM; Ellis RJ; Letendre SL; Mehta SR
    J Neurovirol; 2016 Apr; 22(2):191-200. PubMed ID: 26428514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients.
    Jessen Krut J; Mellberg T; Price RW; Hagberg L; Fuchs D; Rosengren L; Nilsson S; Zetterberg H; Gisslén M
    PLoS One; 2014; 9(2):e88591. PubMed ID: 24523921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased cell-free mitochondrial DNA is a marker of ongoing inflammation and better neurocognitive function in virologically suppressed HIV-infected individuals.
    Pérez-Santiago J; De Oliveira MF; Var SR; Day TRC; Woods SP; Gianella S; Mehta SR
    J Neurovirol; 2017 Apr; 23(2):283-289. PubMed ID: 27921220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of the LPS-LPB-CD14-MD2-TLR4 inflammation pathway in HIV-1/HAART-associated lipodystrophy syndrome (HALS).
    Viladés C; Escoté X; López-Dupla M; Martinez E; Domingo P; Asensi V; Leal M; Peraire J; Inza MI; Arnedo M; Gutiérrez M; Valle-Garay E; Ferrando-Martinez S; Olona M; Alba V; Sirvent JJ; Gatell JM; Vidal F;
    J Antimicrob Chemother; 2014 Jun; 69(6):1653-9. PubMed ID: 24535275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different biological significance of sCD14 and LPS in HIV-infection: importance of the immunovirology stage and association with HIV-disease progression markers.
    Romero-Sánchez M; González-Serna A; Pacheco YM; Ferrando-Martínez S; Machmach K; García-García M; Alvarez-Ríos AI; Vidal F; Leal M; Ruiz-Mateos E
    J Infect; 2012 Nov; 65(5):431-8. PubMed ID: 22728172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of microbial translocation products (LPS, sCD14, IgM Endocab) in HIV-1 infected Indian individuals.
    Negi N; Singh R; Sharma A; Das BK; Vajpayee M
    Microb Pathog; 2017 Oct; 111():331-337. PubMed ID: 28801271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent central nervous system immune activation following more than 10 years of effective HIV antiretroviral treatment.
    Ulfhammer G; Edén A; Mellgren Å; Fuchs D; Zetterberg H; Hagberg L; Nilsson S; Yilmaz A; Gisslén M
    AIDS; 2018 Sep; 32(15):2171-2178. PubMed ID: 30005007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive and Neuronal Link With Inflammation: A Longitudinal Study in People With and Without HIV Infection.
    Anderson AM; Jang JH; Easley KA; Fuchs D; Gisslen M; Zetterberg H; Blennow K; Ellis RJ; Franklin D; Heaton RK; Grant I; Letendre SL
    J Acquir Immune Defic Syndr; 2020 Dec; 85(5):617-625. PubMed ID: 32932412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive increase in central nervous system immune activation in untreated primary HIV-1 infection.
    Suh J; Sinclair E; Peterson J; Lee E; Kyriakides TC; Li FY; Hagberg L; Fuchs D; Price RW; Gisslen M; Spudich S
    J Neuroinflammation; 2014 Dec; 11():199. PubMed ID: 25465205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compartmentalization of cerebrospinal fluid inflammation across the spectrum of untreated HIV-1 infection, central nervous system injury and viral suppression.
    Gisslen M; Keating SM; Spudich S; Arechiga V; Stephenson S; Zetterberg H; Di Germanio C; Blennow K; Fuchs D; Hagberg L; Norris PJ; Peterson J; Shacklett BL; Yiannoutsos CT; Price RW
    PLoS One; 2021; 16(5):e0250987. PubMed ID: 33983973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neopterin and Soluble CD14 Levels as Indicators of Immune Activation in Cases with Indeterminate Pattern and True Positive HIV-1 Infection.
    Uysal HK; Sohrabi P; Habip Z; Saribas S; Kocazeybek E; Seyhan F; Calışkan R; Bonabi E; Yuksel P; Birinci I; Uysal O; Kocazeybek B
    PLoS One; 2016; 11(3):e0152258. PubMed ID: 27031691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated Cerebrospinal Fluid Anti-CD4 Autoantibody Levels in HIV Associate with Neuroinflammation.
    Cheng D; Luo Z; Fu X; Stephenson S; Di Germanio C; Norris PJ; Fuchs D; Ndhlovu LC; Li QZ; Zetterberg H; Gisslen M; Price RW; Peng S; Jiang W
    Microbiol Spectr; 2022 Feb; 10(1):e0197521. PubMed ID: 34985329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Co-Trimoxazole on Microbial Translocation in HIV-1-Infected Patients Initiating Antiretroviral Therapy.
    Vesterbacka J; Barqasho B; Häggblom A; Nowak P
    AIDS Res Hum Retroviruses; 2015 Aug; 31(8):830-6. PubMed ID: 26059763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSF neurofilament protein (NFL) -- a marker of active HIV-related neurodegeneration.
    Abdulle S; Mellgren A; Brew BJ; Cinque P; Hagberg L; Price RW; Rosengren L; Gisslén M
    J Neurol; 2007 Aug; 254(8):1026-32. PubMed ID: 17420923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.